NDC product
Diltiazem Hydrochloride
NDC 62332-815 · Alembic Pharmaceuticals Inc.
Key facts
| Product NDC | 62332-815 |
|---|---|
| Proprietary name | Diltiazem Hydrochloride |
| Nonproprietary name | Diltiazem Hydrochloride |
| Substances | DILTIAZEM HYDROCHLORIDE |
| Dosage form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Labeler | Alembic Pharmaceuticals Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA218587 |
| Pharmacologic classes | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA] |
| Marketing start | Oct 28, 2024 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: